Published in Mol Immunol on December 01, 1995
Major histocompatibility complex heterozygosity reduces fitness in experimentally infected mice. Genetics (2007) 1.03
MHC-genotype of progeny influenced by parental infection. Proc Biol Sci (1998) 1.00
The course of malaria in mice: major histocompatibility complex (MHC) effects, but no general MHC heterozygote advantage in single-strain infections. Genetics (2005) 0.87
Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host. Immunology (2012) 0.76
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell (1978) 7.53
Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci U S A (1976) 5.81
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Cloning of an immunoglobulin variable region gene from mouse embryo. Proc Natl Acad Sci U S A (1977) 3.21
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis (1997) 2.98
Intracisternal A-particle genes as movable elements in the mouse genome. Proc Natl Acad Sci U S A (1983) 2.76
Somatic changes in the content and context of immunoglobulin genes. Cold Spring Harb Symp Quant Biol (1977) 2.73
Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med (2000) 2.61
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Production of functional chimaeric mouse/human antibody. Nature (1985) 2.35
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol (1998) 2.02
Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg (1999) 1.98
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother (1978) 1.81
Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis (1995) 1.74
Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol (2001) 1.67
Defining the relationship between obesity and total joint arthroplasty. Obes Res (2001) 1.58
Secretion of a lambda 2 immunoglobulin chain is prevented by a single amino acid substitution in its variable region. Cell (1983) 1.57
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
RNA splicing mutation in an aberrantly rearranged immunoglobulin lambda I gene. Proc Natl Acad Sci U S A (1981) 1.55
In-vitro comparison of erythromycin, lincomycin, and clindamycin. Br Med J (1970) 1.54
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.45
Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol (1990) 1.43
Hypersensitivity to Colchicine. Ann Rheum Dis (1947) 1.41
Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol (1998) 1.39
What really happens to people on long-term peritoneal dialysis? Kidney Int (1998) 1.37
Molecular cloning of an immunoglobulin kappa constant gene from NZB mouse. Gene (1981) 1.37
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant (1996) 1.37
Association of LY9 in UK and Canadian SLE families. Genes Immun (2008) 1.35
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene (2006) 1.35
Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci U S A (1988) 1.33
Prophylactic activity of cephalosporins in a mouse model of surgical wound infection. J Antibiot (Tokyo) (1983) 1.32
High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32
Lying to military physicians about risk factors for HIV infections. JAMA (1987) 1.26
Focused interviewing in gonorrhea control. Am J Public Health (1980) 1.26
Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin. J Antibiot (Tokyo) (1975) 1.24
Rearrangement of the T-cell receptor beta-chain gene in non-T-cell, non-B-cell acute lymphoblastic leukemia of childhood. N Engl J Med (1985) 1.23
A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals. J Antibiot (Tokyo) (1975) 1.22
Dynamics of immunoglobulin genes. Immunol Rev (1977) 1.22
Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscience (2002) 1.21
Monoclonal antibodies to the Ca2+ + Mg2+-dependent ATPase of sarcoplasmic reticulum identify polymorphic forms of the enzyme and indicate the presence in the enzyme of a classical high-affinity Ca2+ binding site. J Bioenerg Biomembr (1984) 1.19
Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res (2001) 1.19
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer (2011) 1.18
Killing of antigen-reactive B cells by class II-restricted, soluble antigen-specific CD8+ cytolytic T lymphocytes. Nature (1988) 1.18
Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse. Nucleic Acids Res (1982) 1.17
Structure of T cell antigen receptor beta chain in synovial fluid cells from patients with rheumatoid arthritis. Arthritis Rheum (1988) 1.15
Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol (1994) 1.13
Function and evolution of neurofilament proteins. Ann N Y Acad Sci (1985) 1.12
Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature (1986) 1.11
Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia. J Clin Invest (1984) 1.10
Molecular cloning of POEM: a novel adhesion molecule that interacts with alpha8beta1 integrin. J Biol Chem (2001) 1.10
Insertion of a bacterial gene into the mouse germ line using an infectious retrovirus vector. Proc Natl Acad Sci U S A (1985) 1.09
Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals. Antimicrob Agents Chemother (1974) 1.09
Immunoglobulin gene rearrangement in acute myelogenous leukemia. Cancer Res (1984) 1.08
A comparison of rabbit and human skin response to certain irritants. Toxicol Appl Pharmacol (1972) 1.08
Elevation of a gamma delta T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (1991) 1.07
Analysis of hybridoma mutants defective in synthesis of immunoglobulin M. Somat Cell Mol Genet (1986) 1.06
Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant (1998) 1.05
Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis. Arthritis Rheum (1980) 1.05
Antimicrobial activity of SK&F 88070, an expanded-spectrum cephalosporin with high and prolonged levels in blood. Antimicrob Agents Chemother (1984) 1.05
Poly(U) polymerase in rat brain. Nature (1975) 1.04
A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun (2010) 1.03
Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Clin Exp Immunol (1981) 1.03
Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res (1983) 1.03
Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten. Proc Natl Acad Sci U S A (1986) 1.02
A new instrument for the measurement of tissue pO2 of human fetal scalp. Am J Obstet Gynecol (1968) 0.99
The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol (1998) 0.99
Characterization of a mouse DNA clone containing an immunoglobulin variable region gene. Nucleic Acids Res (1978) 0.99
Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry (1994) 0.98
The safety of recombinant factor VIIa in cardiac surgery. Anaesth Intensive Care (2010) 0.98
Visible scars and self-esteem in pediatric patients with burns. J Burn Care Rehabil (1994) 0.97
Lipoteichoic acid-induced neutrophil adhesion via E-selectin to human umbilical vein endothelial cells (HUVECs). Biochem Biophys Res Commun (1995) 0.97
Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol Cell Biol (1988) 0.97
Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain. Proc Natl Acad Sci U S A (1986) 0.95
Amino acid residues in the T cell receptor CDR3 determine the antigenic reactivity patterns of insulin-reactive hybridomas. J Immunol (1991) 0.95
Isolation of a highly cytopathic lentivirus from a nondomestic cat. J Virol (1995) 0.95
Tolerance is overcome in beef insulin-transgenic mice by activation of low-affinity autoreactive T cells. Eur J Immunol (1996) 0.95
Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus. Clin Exp Immunol (1980) 0.95
Coexistence of Fabry's disease and systemic lupus erythematosus. Clin Exp Rheumatol (1998) 0.95
Antifolates induce inhibition of amido phosphoribosyltransferase in leukemia cells. J Biol Chem (1992) 0.94
Antimicrobial activity of aridicins, novel glycopeptide antibiotics with high and prolonged levels in blood. Antimicrob Agents Chemother (1985) 0.94
Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur J Immunol (1990) 0.94
Immunoglobulin genes: a test of somatic vs. germ line hypothesis by RNA-DNA hybridization. Cold Spring Harb Symp Quant Biol (1974) 0.94
Quality of attention in chronic fatigue syndrome: subjective reports of everyday attention and cognitive difficulty, and performance on tasks of focused attention. Br J Clin Psychol (1993) 0.94
Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes. Vox Sang (2009) 0.93
Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells. Clin Cancer Res (1996) 0.93